Correction: Impact of post-transplant cyclophosphamide with bendamustine on immune reconstitution in young patients undergoing T-cell replete haploidentical bone marrow transplantation: results from a phase Ia/Ib clinical trial
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1633590/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850164098453471232 |
|---|---|
| author | Forrest L. Baker Forrest L. Baker Forrest L. Baker Jessica Stokes Megan J. Cracchiolo Dan Davini Richard J. Simpson Richard J. Simpson Richard J. Simpson Richard J. Simpson Emmanuel Katsanis Emmanuel Katsanis Emmanuel Katsanis Emmanuel Katsanis |
| author_facet | Forrest L. Baker Forrest L. Baker Forrest L. Baker Jessica Stokes Megan J. Cracchiolo Dan Davini Richard J. Simpson Richard J. Simpson Richard J. Simpson Richard J. Simpson Emmanuel Katsanis Emmanuel Katsanis Emmanuel Katsanis Emmanuel Katsanis |
| author_sort | Forrest L. Baker |
| collection | DOAJ |
| format | Article |
| id | doaj-art-a3e5a6dba9794ffead30ff2f37120f96 |
| institution | OA Journals |
| issn | 1664-3224 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Immunology |
| spelling | doaj-art-a3e5a6dba9794ffead30ff2f37120f962025-08-20T02:22:04ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-06-011610.3389/fimmu.2025.16335901633590Correction: Impact of post-transplant cyclophosphamide with bendamustine on immune reconstitution in young patients undergoing T-cell replete haploidentical bone marrow transplantation: results from a phase Ia/Ib clinical trialForrest L. Baker0Forrest L. Baker1Forrest L. Baker2Jessica Stokes3Megan J. Cracchiolo4Dan Davini5Richard J. Simpson6Richard J. Simpson7Richard J. Simpson8Richard J. Simpson9Emmanuel Katsanis10Emmanuel Katsanis11Emmanuel Katsanis12Emmanuel Katsanis13School of Nutritional Sciences and Wellness, University of Arizona, Tucson, AZ, United StatesDepartment of Pediatrics, University of Arizona, Tucson, AZ, United StatesThe University of Arizona Cancer Center, Tucson, AZ, United StatesDepartment of Pediatrics, University of Arizona, Tucson, AZ, United StatesDepartment of Pediatrics, University of Arizona, Tucson, AZ, United StatesDepartment of Pediatrics, University of Arizona, Tucson, AZ, United StatesSchool of Nutritional Sciences and Wellness, University of Arizona, Tucson, AZ, United StatesDepartment of Pediatrics, University of Arizona, Tucson, AZ, United StatesThe University of Arizona Cancer Center, Tucson, AZ, United StatesDepartment of Immunobiology, University of Arizona, Tucson, AZ, United StatesDepartment of Pediatrics, University of Arizona, Tucson, AZ, United StatesThe University of Arizona Cancer Center, Tucson, AZ, United StatesDepartment of Immunobiology, University of Arizona, Tucson, AZ, United StatesBanner University Medical Center, Tucson, AZ, United Stateshttps://www.frontiersin.org/articles/10.3389/fimmu.2025.1633590/fullbendamustinecyclophosphamidehematopoietic cell transplantationTCR-β sequencingT-cellscytomegalovirus |
| spellingShingle | Forrest L. Baker Forrest L. Baker Forrest L. Baker Jessica Stokes Megan J. Cracchiolo Dan Davini Richard J. Simpson Richard J. Simpson Richard J. Simpson Richard J. Simpson Emmanuel Katsanis Emmanuel Katsanis Emmanuel Katsanis Emmanuel Katsanis Correction: Impact of post-transplant cyclophosphamide with bendamustine on immune reconstitution in young patients undergoing T-cell replete haploidentical bone marrow transplantation: results from a phase Ia/Ib clinical trial Frontiers in Immunology bendamustine cyclophosphamide hematopoietic cell transplantation TCR-β sequencing T-cells cytomegalovirus |
| title | Correction: Impact of post-transplant cyclophosphamide with bendamustine on immune reconstitution in young patients undergoing T-cell replete haploidentical bone marrow transplantation: results from a phase Ia/Ib clinical trial |
| title_full | Correction: Impact of post-transplant cyclophosphamide with bendamustine on immune reconstitution in young patients undergoing T-cell replete haploidentical bone marrow transplantation: results from a phase Ia/Ib clinical trial |
| title_fullStr | Correction: Impact of post-transplant cyclophosphamide with bendamustine on immune reconstitution in young patients undergoing T-cell replete haploidentical bone marrow transplantation: results from a phase Ia/Ib clinical trial |
| title_full_unstemmed | Correction: Impact of post-transplant cyclophosphamide with bendamustine on immune reconstitution in young patients undergoing T-cell replete haploidentical bone marrow transplantation: results from a phase Ia/Ib clinical trial |
| title_short | Correction: Impact of post-transplant cyclophosphamide with bendamustine on immune reconstitution in young patients undergoing T-cell replete haploidentical bone marrow transplantation: results from a phase Ia/Ib clinical trial |
| title_sort | correction impact of post transplant cyclophosphamide with bendamustine on immune reconstitution in young patients undergoing t cell replete haploidentical bone marrow transplantation results from a phase ia ib clinical trial |
| topic | bendamustine cyclophosphamide hematopoietic cell transplantation TCR-β sequencing T-cells cytomegalovirus |
| url | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1633590/full |
| work_keys_str_mv | AT forrestlbaker correctionimpactofposttransplantcyclophosphamidewithbendamustineonimmunereconstitutioninyoungpatientsundergoingtcellrepletehaploidenticalbonemarrowtransplantationresultsfromaphaseiaibclinicaltrial AT forrestlbaker correctionimpactofposttransplantcyclophosphamidewithbendamustineonimmunereconstitutioninyoungpatientsundergoingtcellrepletehaploidenticalbonemarrowtransplantationresultsfromaphaseiaibclinicaltrial AT forrestlbaker correctionimpactofposttransplantcyclophosphamidewithbendamustineonimmunereconstitutioninyoungpatientsundergoingtcellrepletehaploidenticalbonemarrowtransplantationresultsfromaphaseiaibclinicaltrial AT jessicastokes correctionimpactofposttransplantcyclophosphamidewithbendamustineonimmunereconstitutioninyoungpatientsundergoingtcellrepletehaploidenticalbonemarrowtransplantationresultsfromaphaseiaibclinicaltrial AT meganjcracchiolo correctionimpactofposttransplantcyclophosphamidewithbendamustineonimmunereconstitutioninyoungpatientsundergoingtcellrepletehaploidenticalbonemarrowtransplantationresultsfromaphaseiaibclinicaltrial AT dandavini correctionimpactofposttransplantcyclophosphamidewithbendamustineonimmunereconstitutioninyoungpatientsundergoingtcellrepletehaploidenticalbonemarrowtransplantationresultsfromaphaseiaibclinicaltrial AT richardjsimpson correctionimpactofposttransplantcyclophosphamidewithbendamustineonimmunereconstitutioninyoungpatientsundergoingtcellrepletehaploidenticalbonemarrowtransplantationresultsfromaphaseiaibclinicaltrial AT richardjsimpson correctionimpactofposttransplantcyclophosphamidewithbendamustineonimmunereconstitutioninyoungpatientsundergoingtcellrepletehaploidenticalbonemarrowtransplantationresultsfromaphaseiaibclinicaltrial AT richardjsimpson correctionimpactofposttransplantcyclophosphamidewithbendamustineonimmunereconstitutioninyoungpatientsundergoingtcellrepletehaploidenticalbonemarrowtransplantationresultsfromaphaseiaibclinicaltrial AT richardjsimpson correctionimpactofposttransplantcyclophosphamidewithbendamustineonimmunereconstitutioninyoungpatientsundergoingtcellrepletehaploidenticalbonemarrowtransplantationresultsfromaphaseiaibclinicaltrial AT emmanuelkatsanis correctionimpactofposttransplantcyclophosphamidewithbendamustineonimmunereconstitutioninyoungpatientsundergoingtcellrepletehaploidenticalbonemarrowtransplantationresultsfromaphaseiaibclinicaltrial AT emmanuelkatsanis correctionimpactofposttransplantcyclophosphamidewithbendamustineonimmunereconstitutioninyoungpatientsundergoingtcellrepletehaploidenticalbonemarrowtransplantationresultsfromaphaseiaibclinicaltrial AT emmanuelkatsanis correctionimpactofposttransplantcyclophosphamidewithbendamustineonimmunereconstitutioninyoungpatientsundergoingtcellrepletehaploidenticalbonemarrowtransplantationresultsfromaphaseiaibclinicaltrial AT emmanuelkatsanis correctionimpactofposttransplantcyclophosphamidewithbendamustineonimmunereconstitutioninyoungpatientsundergoingtcellrepletehaploidenticalbonemarrowtransplantationresultsfromaphaseiaibclinicaltrial |